Preliminary reports suggest conolidine may inhibit certain ion channels, reducing neuronal excitability and restricting discomfort signals. This mechanism is particularly applicable in neuropathic discomfort, wherever abnormal signaling leads to persistent irritation. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to agony perception. Co... https://christopherb360gkn0.bleepblogs.com/profile